FXStreet reports that according to economists at MUFG Bank, further restrictions under a Biden presidency are on the cards.
“Risks remain elevated and news that Astra Zeneca will run an additional trial to try and validate the 90% efficacy rate in results from a portion of its trial is concerning. Clearly, the biggest single risk for financial markets now is the failure of vaccines being rolled out smoothly in Q1 2021.”
“On three days over the past week, the US has reported a daily death total over the 2,000 level. On average over the past week, the US has recorded 175K new cases per day”
“The latest available data is to Wednesday and the mobility figures were the highest for a Wednesday since 14th October. So the next few weeks could see the consequences of Thanksgiving in a further escalation of infections and deaths.”
“There are certainly increasing calls for a national strategy to tackle the virus and it seems likely with COVID-19 figures set to be elevated when Joe Biden becomes president in January that greater restrictions are on the way. If the rest of the world is recovering by then, it could result in further reason to sell the dollar.”
© 2000-2024. All rights reserved.
This site is managed by Teletrade D.J. LLC 2351 LLC 2022 (Euro House, Richmond Hill Road, Kingstown, VC0100, St. Vincent and the Grenadines).
The information on this website is for informational purposes only and does not constitute any investment advice.
The company does not serve or provide services to customers who are residents of the US, Canada, Iran, The Democratic People's Republic of Korea, Yemen and FATF blacklisted countries.
Making transactions on financial markets with marginal financial instruments opens up wide possibilities and allows investors who are willing to take risks to earn high profits, carrying a potentially high risk of losses at the same time. Therefore you should responsibly approach the issue of choosing the appropriate investment strategy, taking the available resources into account, before starting trading.
Use of the information: full or partial use of materials from this website must always be referenced to TeleTrade as the source of information. Use of the materials on the Internet must be accompanied by a hyperlink to teletrade.org. Automatic import of materials and information from this website is prohibited.
Please contact our PR department if you have any questions or need assistance at pr@teletrade.global.